Skip to content

THE EFFECT OF VAMANA AND VIRECHANA KARMA FOLLOWED BY LEKHANA BASTI IN obesity

THE EFFECT OF VAMANA AND VIRECHANA KARMA FOLLOWED BY LEKHANA BASTI IN THE MANAGEMENT OF STHAULYA WSR TO OBESITY A COMPARATIVE STUDY - VVB

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/02/006616
Enrollment
60
Registered
2016-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Sthaulya

Interventions

Intervention1: In this group classical Vamana Karma will be administered followed by Lekhana Basti.: Contents Maksika Honey 200 ml Lavana Rock salt 15 gm Sneha-Murchhita Tila Tailam Sesame oil 200 m

Sponsors

Institute for Post graduate teaching and research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having classical sign and symptoms of Sthaulya like Chala Udara, Stana, Sphika, Javoparadha, Kruchravyavaya, Durbalata, Atikshudha, Atitrishna etc. Patient having sign and symptoms of Obesity like, Large body frame, Having extra fat around the waist, Difficulty in doing daily activities, Lethargy, Breathlessness, Increased weight, Snoring, Heavy sweating, Difficulty while sleeping Etc. Age- 18-60 years B.M.I - >25 & B.M.I. Prime- >1.00 Waist-hip ratio: Male: >0.95 Female: >0.80

Exclusion criteria

Exclusion criteria: Patients having age less than 18 years & above 60 years. Patients having serious cardiac, renal and hepatic diseases etc. Patients having major illness like Diabetes Mellitus which is poorly controlled. Patients having history of uncontrolled Hypertension and other endocrine diseases. Obesity due to drugs e.g. Anticonvulsant, antipsychotics, Beta-blockers etc Pregnant females & lactating women. Patients unfit for Shodhana therapy BMI >40 will be excluded. Waist-Hip ratio: Man: 0.95 or below Female: 0.80 or below

Design outcomes

Primary

MeasureTime frame
It is expected that the trial drugs will exert a significant action over sthaulyaTimepoint: four weeks

Secondary

MeasureTime frame
By maintaining weight,drug will control associated symptoms of Sthaulya like Chala Udara, Stana, Sphika, Javoparadha, Kruchravyavaya, Durbalata, Atikshudha, AtitrishnaTimepoint: Four weeks

Countries

India

Contacts

Public ContactAnup Thakar

IPGT and RA

anup_thakar@yahoo.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026